BALTIMORE, Jan. 8, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Alliance Foundation Trials, LLC (AFT) for research use of Haystack Oncology's personalized MRD technology (Haystack MRD™) to analyze therapeutic response and provide molecular insights for AFT's interventional, randomized phase II clinical trial (AFT-57) in patients with unresectable stage III non-small cell lung cancer (NSCLC). The AFT-57 clinical study is supported by G ...

Quest Diagnostics Inc. (DGX) is likely to grow in the coming quarters, backed by strength in the legacy base business. The company is gaining from collaborations with health plans, hospitals and physicians amid a broad return to care. However, a high debt level on the balance sheet and intense competition also raise concerns.In the past year, this Zacks Rank #3 (Hold) stock has declined 8.9% against the industry’s 9% growth and a 24.5% rise of the S&P 500 composite.The renowned provider of diagnostic inform ...

SECAUCUS, N.J., Dec. 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance, and the latest market developments and trends during a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024, at 6:45 p.m. ...

Quest Diagnostics Inc. (NYSE:DGX) Q3 2023 Results Conference Call October 24, 2023 8:30 AM ET Company Participants Shawn Bevec - VP, IR Jim Davis - Chairman, President & CEO Sam Samad - CFO Conference Call Participants Ann Hynes - Mizuho Securities David Westenberg - Piper Sandler Kieran Ryan - Deutsche Bank Elizabeth Anderson - Evercore Kevin Caliendo - UBS Jack Meehan - Nephron Research Patrick Donnelly - Citi Erin Wright - Morgan Stanley Brian Tanquilut - Jefferies Lisa Gill - JP Morgan Operator Welcome ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated 500 Plaza Drive Indicate by check mark whether the registrant has submi ...

Quest Diagnostics, Inc. (NYSE:DGX) Q2 2023 Earnings Conference Call July 26, 2023 8:30 AM ET Company Participants Shawn Bevec - VP, IR James Davis - Chairman, CEO & President Sam Samad - EVP & CFO Conference Call Participants Jack Meehan - Nephron Research Elizabeth Anderson - Evercore ISI A.J. Rice - Crédit Suisse Lisa Gill - JPMorgan Chase & Co. Eric Coldwell - Robert W. Baird & Co. Philip Chickering - Deutsche Bank Brian Tanquilut - Jefferies Kevin Caliendo - UBS Patrick Donnelly - Citigroup Operator Wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 500 Plaza Drive (State of Incorporation) (I.R.S. Employer Identification Number) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly perio ...

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Shawn Bevec - Vice President, Investor Relations Jim Davis - Chairman and Chief Executive Officer and President Sam Samad - Chief Financial Officer. Conference Call Participants Ann Hynes - Mizuho Securities Patrick Donnelly - Citigroup Brian Tanquilut - Jefferies Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Jack Meehan - Nephron Research Erin Wright - Morgan Stanley Kieran Rya ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 500 Plaza Drive (State of Incorporation) (I.R.S. Employ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number 001-12215 Quest Diagnostics Incorporated 500 Plaza Drive Secaucus, NJ 07094 (973) 520-2700 Delaware 16-1387862 ...